280 related articles for article (PubMed ID: 32473077)
1. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
2. CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts.
Aoki M; Koga K; Miyazaki M; Hamasaki M; Koshikawa N; Oyama M; Kozuka-Hata H; Seiki M; Toole BP; Nabeshima K
BMC Cancer; 2019 Sep; 19(1):912. PubMed ID: 31510956
[TBL] [Abstract][Full Text] [Related]
3. Poorly Differentiated Clusters Predict a Poor Prognosis for External Auditory Canal Carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Kiyomi F; Sakata T; Nakagawa T; Nabeshima K
Head Neck Pathol; 2019 Jun; 13(2):198-207. PubMed ID: 29846906
[TBL] [Abstract][Full Text] [Related]
4. MMP-2 Regulation of Emmprin on Tumour Cells and CD73 on Fibroblasts During Tumour-Stromal Interaction.
Aoki M; Tsunoda T; Koga K; Nabeshima K; Hamasaki M
Anticancer Res; 2023 Aug; 43(8):3735-3745. PubMed ID: 37500155
[TBL] [Abstract][Full Text] [Related]
5. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
[TBL] [Abstract][Full Text] [Related]
6. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
Zheng HC; Takahashi H; Murai Y; Cui ZG; Nomoto K; Miwa S; Tsuneyama K; Takano Y
Br J Cancer; 2006 Nov; 95(10):1371-8. PubMed ID: 17088917
[TBL] [Abstract][Full Text] [Related]
7. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Sienel W; Polzer B; Elshawi K; Lindner M; Morresi-Hauf A; Vay C; Eder F; Passlick B; Klein CA
Mod Pathol; 2008 Sep; 21(9):1130-8. PubMed ID: 18567995
[TBL] [Abstract][Full Text] [Related]
8. Emmprin, released as a microvesicle in epithelioid sarcoma, interacts with fibroblasts.
Aoki M; Koga K; Hamasaki M; Egawa N; Nabeshima K
Int J Oncol; 2017 Jun; 50(6):2229-2235. PubMed ID: 28498412
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC.
Ishii H; Azuma K; Kawahara A; Kinoshita T; Matsuo N; Naito Y; Tokito T; Yamada K; Akiba J; Hoshino T
Thorac Cancer; 2020 Apr; 11(4):950-955. PubMed ID: 32061060
[TBL] [Abstract][Full Text] [Related]
10. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
Kim HS; Kim HJ; Lee MR; Han I
BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
[TBL] [Abstract][Full Text] [Related]
11. Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP.
Suzuki S; Sato M; Senoo H; Ishikawa K
Exp Cell Res; 2004 Feb; 293(2):259-66. PubMed ID: 14729463
[TBL] [Abstract][Full Text] [Related]
12. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
[TBL] [Abstract][Full Text] [Related]
13. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.
Chen T; Zhu J
Med Oncol; 2010 Dec; 27(4):1185-91. PubMed ID: 19921476
[TBL] [Abstract][Full Text] [Related]
15. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
16. EMMPRIN contributes to the in vitro invasion of human salivary adenoid cystic carcinoma cells.
Yang X; Zhang P; Ma Q; Kong L; Li Y; Liu B; Lei D
Oncol Rep; 2012 Apr; 27(4):1123-7. PubMed ID: 22200897
[TBL] [Abstract][Full Text] [Related]
17. MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.
Bonnin N; Armandy E; Carras J; Ferrandon S; Battiston-Montagne P; Aubry M; Guihard S; Meyronet D; Foy JP; Saintigny P; Ledrappier S; Jung A; Rimokh R; Rodriguez-Lafrasse C; Poncet D
Oncotarget; 2016 Jul; 7(28):44023-44038. PubMed ID: 27281619
[TBL] [Abstract][Full Text] [Related]
18. Expression of emmprin by oral squamous cell carcinoma.
Bordador LC; Li X; Toole B; Chen B; Regezi J; Zardi L; Hu Y; Ramos DM
Int J Cancer; 2000 Feb; 85(3):347-52. PubMed ID: 10652425
[TBL] [Abstract][Full Text] [Related]
19. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma.
Cao Z; Xiang J; Li C
Int J Oral Maxillofac Surg; 2009 Aug; 38(8):880-5. PubMed ID: 19372030
[TBL] [Abstract][Full Text] [Related]
20. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]